BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Treatment
31 results:

  • 1. Mutation detection in saliva from oral cancer patients.
    Ahmed AA; Sborchia M; Bye H; Roman-Escorza M; Amar A; Henley-Smith R; Odell E; McGurk M; Simpson M; Ng T; Sawyer EJ; Mathew CG
    Oral Oncol; 2024 Apr; 151():106717. PubMed ID: 38412584
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
    Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
    Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
    Kim S; Lee C; Kim H; Yoon SO
    Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies.
    Hunt PJ; Amit M; Kabotyanski KE; Aashiq M; Hanna EY; Kupferman ME; Su SY; Gidley PW; Nader ME; DeMonte F; Raza SM
    Neurosurg Rev; 2023 Jun; 46(1):157. PubMed ID: 37386212
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma.
    Dogan S; Xu B; Rana S; Chen H; Ghossein RA; Berger MF; Ho AL; Katabi N
    Mod Pathol; 2023 Jul; 36(7):100150. PubMed ID: 36841437
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Primary concurrent chemoradiation therapy with triweekly cisplatin as a standard protocol in patients aged ≥65 years with head and neck squamous cell carcinoma.
    Ahn D; Kwak JH; Lee GJ; Sohn JH; Lee JE
    Asia Pac J Clin Oncol; 2023 Oct; 19(5):e239-e247. PubMed ID: 36178306
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer.
    Mai Z; Yuan J; Yang H; Fang S; Xie X; Wang X; Xie J; Wen J; Fu J
    JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35993362
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The diverse functions of fat1 in cancer progression: good, bad, or ugly?
    Chen ZG; Saba NF; Teng Y
    J Exp Clin Cancer Res; 2022 Aug; 41(1):248. PubMed ID: 35965328
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4.
    Chen N; Golczer G; Ghose S; Lin B; Langenbucher A; Webb J; Bhanot H; Abt NB; Lin D; Varvares M; Sattler M; Egloff AM; Joh R; Uppaluri R; Emerick KS; Lawrence MS; Saladi SV
    Cell Rep; 2022 Jun; 39(11):110970. PubMed ID: 35705032
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications.
    Osawa Y; Aoyama KI; Hosomichi K; Uchibori M; Tajima A; Kimura M; Ota Y
    Cancer Treat Res Commun; 2021; 29():100456. PubMed ID: 34563788
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Significance of Circular fat1 as a Prognostic Factor and Tumor Suppressor for Esophageal Squamous Cell Carcinoma.
    Takaki W; Konishi H; Shoda K; Arita T; Kataoka S; Shibamoto J; Furuke H; Takabatake K; Shimizu H; Komatsu S; Shiozaki A; Fujiwara H; Masuda K; Otsuji E
    Ann Surg Oncol; 2021 Dec; 28(13):8508-8518. PubMed ID: 34185205
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
    Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
    ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options.
    Modesto A; Siegfried A; Lusque A; Vergez S; Sarini J; Brouchet L; Uro-Coste E; Graff-Cailleaud P; Delord JP
    Curr Oncol; 2021 Apr; 28(3):1673-1680. PubMed ID: 33947015
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
    Huang C; Chen L; Savage SR; Eguez RV; Dou Y; Li Y; da Veiga Leprevost F; Jaehnig EJ; Lei JT; Wen B; Schnaubelt M; Krug K; Song X; Cieślik M; Chang HY; Wyczalkowski MA; Li K; Colaprico A; Li QK; Clark DJ; Hu Y; Cao L; Pan J; Wang Y; Cho KC; Shi Z; Liao Y; Jiang W; Anurag M; Ji J; Yoo S; Zhou DC; Liang WW; Wendl M; Vats P; Carr SA; Mani DR; Zhang Z; Qian J; Chen XS; Pico AR; Wang P; Chinnaiyan AM; Ketchum KA; Kinsinger CR; Robles AI; An E; Hiltke T; Mesri M; Thiagarajan M; Weaver AM; Sikora AG; Lubiński J; Wierzbicka M; Wiznerowicz M; Satpathy S; Gillette MA; Miles G; Ellis MJ; Omenn GS; Rodriguez H; Boja ES; Dhanasekaran SM; Ding L; Nesvizhskii AI; El-Naggar AK; Chan DW; Zhang H; Zhang B;
    Cancer Cell; 2021 Mar; 39(3):361-379.e16. PubMed ID: 33417831
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
    Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
    Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Translational genomics and recent advances in oral squamous cell carcinoma.
    Chai AWY; Lim KP; Cheong SC
    Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and fat1 expressions.
    Kuo TM; Nithiyanantham S; Lee CP; Hsu HT; Luo SY; Lin YZ; Yeh KT; Ko YC
    J Cell Physiol; 2019 Aug; 234(8):13984-13993. PubMed ID: 30624777
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: A case report.
    Ren W; Sun Q; Wu PY; Huang B; Yang J; Yan J; Liu BR
    Medicine (Baltimore); 2018 Nov; 97(48):e13413. PubMed ID: 30508944
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Screening and clinical significance of tumor markers in head and neck squamous cell carcinoma through bioinformatics analysis.
    Zhao L; Chi W; Cao H; Cui W; Meng W; Guo W; Wang B
    Mol Med Rep; 2019 Jan; 19(1):143-154. PubMed ID: 30431092
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.